Eumycetoma caused by Cladophialophora bantiana successfully treated with itraconazole

Medical Mycology

Volumn 47, Issue 1, 2009, Pages 111-114

  Bonifaz, Alexandro ^a   Hoog, Sybren ^b   Mcginnis, Michael ^c   Saúl, Amado ^a   Rodríguez Cortés, Octavio ^a   Araiza, Javier ^a   Cruz, Mariana ^a   Mercadillo, Patricia ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cladophialophora bantiana; Eumycetoma; Itraconazole; Mycetoma; Phaeohyphomycosis

Indexed keywords

ANTIBIOTIC AGENT; FUNGAL DNA; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ADULT; ARTICLE; CASE REPORT; CLADOPHIALOPHORA BANTIANA; CLINICAL FEATURE; DNA SEQUENCE; DRUG DOSE REDUCTION; DRUG EFFICACY; EUMYCETOMA; EXUDATE; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SKIN BIOPSY; SKIN INFECTION; TREATMENT DURATION;

ANTIFUNGAL AGENTS; ASCOMYCOTA; FOOT DERMATOSES; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; MYCETOMA; TREATMENT OUTCOME;

CLADOPHIALOPHORA BANTIANA; FUNGI;

EID: 58149196257     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802430639     Document Type: Article

References (24)

1. Mahgoub, ES. (1985) Mycetoma. Semin Dermatol, 4, pp. 230-239.
2. McGinnis, MR. (1996) Mycetoma. Dermatol Clinics, 14, pp. 97-104.
3. Welsh, O. (1993) Mycetoma. Semin Dermatol, 12, pp. 290-295.
4. Fahal, AH. (2004) Mycetoma: A thorn in the flesh. Trans R Soc Trop Med Hyg, 98, pp. 3-11.
5. Lichon, V. and Khachemoune, A. (2006) Mycetoma: A review. Am J Clin Dermatol, 7, pp. 315-321.
6. McGinnis, MR. (1983) Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycology. J Am Acad Dermatol, 8, pp. 1-16.
7. Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A. and Rinaldi, MG. (2002) Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol, 40, pp. 3776-3781.
8. Kuzucu, C., Rapino, B., McDermott, L. and Hadley, S. (2004) Comparison of the semisolid agar antifungal susceptibility test with the NCCLS M38-P broth microdilution test for screening of filamentous fungi. J Clin Microbiol, 42, pp. 1224-1227.
9. Sanche, SE, Sutton, DA and Rinaldi, MG (2003) Dematiaceous fungi. Clinical Mycology, pp. 325-351. Churchill-Livingstone, Philadelphia
10. Brandt, ME and Warnock, DW. (2003) Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother, 15, pp. 36-47.
11. Pardo, F., Ferrer, E., Romero, PA and Perez del Molino, ML. (2006) Cerebral phaeohyphomycosis due to Cladophialophora bantiana. Enferm Infecc Microbiol Clin, 24, pp. 593-594.
12. Delfino, D., De Hoog, S. Polonelli, L. et al. (2006) Survival of a neglected case of brain abscess caused by Cladophialophora bantiana. Med Mycol, 44, pp. 651-654.
13. Revankar, SG, Sutton, DA and Rinaldi, MG. (2004) Primary central nervous system phaeohyphomycosis: A review of 101 cases. Clin Infect Dis, 38, pp. 206-216.
14. Patterson, JW, Warren, NG and Kelly, LW. (1999) Cutaneous phaeohyphomycosis due to Cladophialophora bantiana. J Am Acad Dermatol, 40, pp. 364-366.
15. Love, GL. (2006) Subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana. Arch Pathol Lab Med, 130, p. 146.
16. Hussey, SM, Gander, R., Southern, P. and Hoang, MP. (2005) Subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana. Arch Pathol Lab Med, 129, pp. 794-797.
17. Guillot, J., Garcia-Hermoso, D. Degorce, F. et al. (2004) Eumycetoma caused by Cladophialophora bantiana in a dog. J Clin Microbiol, 42, pp. 4901-4903.
18. Werlinger, KD and Yen-Moore, A. (2005) Eumycotic mycetoma caused by Cladophialophora bantiana in a patient with systemic lupus erythematosus. J Am Acad Dermatol, 52, p. S114.
19. Welsh, O., Salinas, MC and Rodriguez, MA. (1995) Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol, 6, pp. 47-71.
20. Poncio-Mendez, R., Negroni, R., Bonifaz, A. and Pappagianis, D. (2000) New aspects of some endemic mycoses. Med Mycol, 38, pp. 237-241.
21. Ahmed, AA, van de Sande, WW Fahal, A. et al. (2007) Management of mycetoma: Major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis, 20, pp. 146-151.
22. Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A. and Rinaldi, MG. (2002) Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol, 40, pp. 3776-3781.
23. Sharkey, PK, Graybill, JR Rinaldi, MG et al. (1990) Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol, 23, pp. 577-586.
24. Al-Abdely, HM, Najvar, LK, Bocanegra, R. and Graybill, JR. (2005) Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana. Antimicrob Agents Chemother, 49, pp. 1701-1707.